IgE plasma cells are transcriptionally and functionally distinct from other isotypes.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
06 Sep 2024
Historique:
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 6 9 2024
Statut: ppublish

Résumé

Understanding the phenotypic and transcriptional signature of immunoglobulin E (IgE)-producing cells is fundamental to plasma cell (PC) biology and development of therapeutic interventions for allergy. Here, using a mouse model of intranasal house dust mite (HDM) exposure, we showed that short-lived IgE PCs emerge in lung draining lymph nodes (dLNs) during early exposure (<3 weeks) and long-lived IgE PCs accumulate in the bone marrow (BM) with prolonged exposure (>7 weeks). IgE PCs had distinct surface and gene expression profiles in these different tissues compared with other Ig isotypes. IgE BMPCs up-regulated genes associated with prosurvival and BM homing, whereas IgE dLN PCs expressed genes associated with recent class switching and differentiation. IgE PCs also exhibited higher expression of endoplasmic reticulum (ER) stress and protein coding genes and higher antibody secretion rate when compared with IgG1. Overall, this study highlights the unique developmental path and transcriptional signature of short-lived and long-lived IgE PCs.

Identifiants

pubmed: 39241058
doi: 10.1126/sciimmunol.adm8964
doi:

Substances chimiques

Immunoglobulin E 37341-29-0
Immunoglobulin Isotypes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadm8964

Auteurs

Andrea Vecchione (A)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Joseph C Devlin (JC)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Carley Tasker (C)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Venkat Raman Ramnarayan (VR)

Institut Pasteur, Université Paris Cité, Inserm UMR1222, Antibodies in Therapy and Pathology, 75015 Paris, France.

Paul Haase (P)

Institut Pasteur, Université Paris Cité, Inserm UMR1222, Antibodies in Therapy and Pathology, 75015 Paris, France.

Eva Conde (E)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Devin Srivastava (D)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Gurinder S Atwal (GS)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Pierre Bruhns (P)

Institut Pasteur, Université Paris Cité, Inserm UMR1222, Antibodies in Therapy and Pathology, 75015 Paris, France.

Andrew J Murphy (AJ)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Matthew A Sleeman (MA)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Andre Limnander (A)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Wei Keat Lim (WK)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Seblewongel Asrat (S)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Jamie M Orengo (JM)

Regeneron Pharmaceuticals, Tarrytown, New York, 10591, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH